37 results
8-K
EX-3.2
LSTA
Lisata Therapeutics Inc
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-3.1
LSTA
Lisata Therapeutics Inc
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-3.1
LSTA
Lisata Therapeutics Inc
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
8-K
EX-3.1
LSTA
Lisata Therapeutics Inc
21 Sep 17
Material Modifications to Rights of Security Holders
12:00am
10-Q
2016 Q2
EX-3.2
LSTA
Lisata Therapeutics Inc
Quarterly report
9 Aug 16
12:00am
8-K
EX-3.1
ya036kzs blhlcm
27 Jul 16
Caladrius Biosciences Announces 1-for-10 Reverse Split
12:00am
8-K
EX-3.2
d4zo b73f
27 Jul 16
Caladrius Biosciences Announces 1-for-10 Reverse Split
12:00am
8-K
EX-3.1
r1m10 zch2a90
5 Jun 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
5k0dqm
5 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
ugc4unw yfcm
3 Oct 13
NeoStem Announces Proposed Public Offering of Common Stock
12:00am
8-K
EX-3.1
3cl3ogaijhp
12 Jul 13
NeoStem Announces 1-for-10 Reverse Split
12:00am
8-K
EX-3.1
x8u0rdfsyu80c
25 Oct 12
NeoStem, Inc. Announces the Redemption of the Outstanding 7% Series E Preferred Stock
12:00am
8-K
EX-3.1
35rmgui6
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am